Brian Windsor, Ph.D.
Board Member
Rein Therapeutics, Inc. (RNTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Windsor, Ph.D.
Brian Windsor, Ph.D. is recorded as Board Member, CEO and COO at Rein Therapeutics, Inc. (RNTX). Rein Therapeutics, Inc. reported in an 8-K filed March 15, 2024 that Brian Windsor, Ph.D. was appointed Chief Executive Officer, effective March 11, 2024. Rein Therapeutics, Inc. reported in an 8-K filed March 15, 2024 that Brian Windsor, Ph.D. was appointed member of the Board, effective March 11, 2024.
“On March 11, 2024, the Board elected Brian Windsor, Ph.D., as the Chief Executive Officer of the Company and a member of the Board, effective as of March 11, 2024.”
“On March 11, 2024, the Board elected Brian Windsor, Ph.D., as the Chief Executive Officer of the Company and a member of the Board, effective as of March 11, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-03-11–present
-
Current
2024-03-11–present
-
Current
2023-10-31–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor CEO, COO, Board Member
- Josef H. von Rickenbach Chairman, Board Member
- Charles Garner CFO
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Alan A. Musso Board Member
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
- Reinhard J. Ambros Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.